[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 2, 1967

Clinical Pharmacology and Experimental Therapeutics

Author Affiliations

Kalamazoo, Mich

JAMA. 1967;202(1):71-72. doi:10.1001/jama.1967.03130140129033

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Re the letter of Dr. Frederic L. Stone (201:705, 1967) concerning Clinical Pharmacology and Experimental Therapeutics, no amount of "word salad" in our age of tyranny on words can mask for long to the discerning that the National Institutes of Health activities have been appropriately and accurately and justly described by Dr. John H. Moyer (200:454, 1967). It would seem they have indeed failed to support appropriately the development of experimental therapeutics in the United States. Basic science and basic research are essential in our society, and no thinking man, including Dr. Moyer, would think of denying their appropriate place. When, however, many of these endeavors are supported to the exclusion of applied research in an area as important as human therapeutics, and when men well qualified in basic science and basic research inappropriately assume the role of major decision makers for such areas of